Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Characterization of the CCK-B/gastrin-like receptor in human colon cancer.

Smith JP, Stock EA, Wotring MG, McLaughlin PJ, Zagon IS.

Am J Physiol. 1996 Sep;271(3 Pt 2):R797-805.

PMID:
8853405
2.

Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines.

Smith JP, Liu G, Soundararajan V, McLaughlin PJ, Zagon IS.

Am J Physiol. 1994 Jan;266(1 Pt 2):R277-83.

PMID:
8304551
3.

Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma.

Smith JP, Shih AH, Wotring MG, McLaughlin PJ, Zagon IS.

Int J Oncol. 1998 Feb;12(2):411-9.

PMID:
9458369
4.

Identification of gastrin as a growth peptide in human pancreatic cancer.

Smith JP, Fantaskey AP, Liu G, Zagon IS.

Am J Physiol. 1995 Jan;268(1 Pt 2):R135-41.

PMID:
7840313
5.

Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.

Stepan VM, Sawada M, Todisco A, Dickinson CJ.

Mol Med. 1999 Mar;5(3):147-59.

6.

Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide.

Hoosein NM, Kiener PA, Curry RC, Brattain MG.

Exp Cell Res. 1990 Jan;186(1):15-21.

PMID:
2298233
7.

Cholecystokinin receptors and PANC-1 human pancreatic cancer cells.

Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS.

Am J Physiol. 1993 Jul;265(1 Pt 1):G149-55.

PMID:
8338163
8.

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.

Mol Pharmacol. 1989 Jun;35(6):803-8.

PMID:
2733696
9.

CCK-B/gastrin receptors in human colorectal cancer.

Schmitz F, Otte JM, Stechele HU, Reimann B, Banasiewicz T, Fölsch UR, Schmidt WE, Herzig KH.

Eur J Clin Invest. 2001 Sep;31(9):812-20. Erratum in: Eur J Clin Invest 2002 Jan;32(1):69.

PMID:
11589724
10.

YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.

Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.

Aliment Pharmacol Ther. 1997 Feb;11(1):113-20.

11.

Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells.

Schmitz F, Schrader H, Otte J, Schmitz H, Stüber E, Herzig K, Schmidt WE.

Regul Pept. 2001 Sep 15;101(1-3):25-33. Erratum in: Regul Pept 2001 Dec 15;102(2-3):165.

PMID:
11495676
12.

Identification and characterization of zeta-opioid receptor in human colon cancer.

Hytrek SD, Smith JP, McGarrity TJ, McLaughlin PJ, Lang CM, Zagon IS.

Am J Physiol. 1996 Jul;271(1 Pt 2):R115-21.

PMID:
8760211
14.

Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B.

Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC.

Biochem Biophys Res Commun. 1994 Aug 15;202(3):1222-6.

PMID:
8060296
15.

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.

Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3124s-3138s.

PMID:
10541353
16.

Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon.

Clerc P, Dufresne M, Saillan C, Chastre E, André T, Escrieut C, Kennedy K, Vaysse N, Gespach C, Fourmy D.

Int J Cancer. 1997 Sep 17;72(6):931-6.

17.

Effects of gastrin, proglumide, loxiglumide and L-365,260 on growth of human colon carcinoma cells.

Mauss S, Niederau C, Hengels KJ.

Anticancer Res. 1994 Jan-Feb;14(1A):215-20.

PMID:
8166452
20.
Items per page

Supplemental Content

Support Center